Heavy metal cadmium (Cd), a classical
environmental pollutant, causes placental apoptosis and
fetal growth restriction (FGR), whereby the mechanism remains unclear. Here, our human case-control study firstly showed that there was a positive association of Parkin mitochondrial translocation, MCL-1 reduction, placental apoptosis, and all-cause FGR. Subsequently, Cd was administered to establish in vitro and in vivo models of placental apoptosis or FGR. Our models demonstrated that Parkin mitochondrial translocation was observed in Cd-administrated placental trophoblasts. Meaningfully, Parkin
siRNA (siR) dramatically mitigated Cd-triggered apoptosis in placental trophoblasts.
Mdivi-1 (M-1), an inhibitor for Parkin mitochondrial translocation, mitigated Cd-induced apoptosis in placental trophoblasts, which further ameliorated the effect of attenuated placental sizes in Cd-exposed mice. Furthermore, the interaction of MCL-1 with Parkin or Ub in Cd-stimulated cells was stronger than that in controls.
MG132, an inhibitor for
proteasome, abolished MCL-1 degradation in Cd-stimulated cells. Importantly, Parkin siR and M-1 memorably abolished the
ubiquitin-dependent degradation of MCL-1 in placental trophoblasts. Interestingly, mito-
TEMPO and
melatonin, two mitochondria-targeted
antioxidants, obviously rescued Cd-caused mitochondrial membrane potential (
MMP) decrease, Parkin mitochondrial translocation, MCL-1 degradation, and apoptosis in placental trophoblasts. In conclusion,
cadmium induces placental apoptosis and FGR via mtROS-mediated Parkin-modulated degradation of MCL-1.